FDA Clears Syneron Medical’s New VelaShape® III Platform for Abdominal Circumferential Reduction…CE Mark Too!

Aesthetic medical device company Syneron Medical Ltd., has announced FDA clearance and CE mark approval for VelaShape® III, the Company’s new non-invasive body shaping platform. This new platform is said to be effective for temporary reduction in circumference of the abdomen and is also used in a wide range of other body shaping applications such as cellulite treatments.

Syneron Medical Receives FDA Clearance for Abdominal Circumferential Reduction and CE mark for the New VelaShape® III Platform (via PR Newswire)

Download image Download image Syneron Medical Ltd logo IRVINE, California, September 10, 2013 /PRNewswire/ —   In a clinical study of forty-two patients, an average abdominal circumference reduction of 2.6 cm was achieved following a single VelaShape…

published: September 11, 2013 in: Approval/Clearance, Plastic/Reconstructive

Most read

Latest

^